Amelia Insa

Amelia Insa

UNVERIFIED PROFILE

Are you Amelia Insa?   Register this Author

Register author
Amelia Insa

Amelia Insa

Publications by authors named "Amelia Insa"

Are you Amelia Insa?   Register this Author

22Publications

954Reads

40Profile Views

In the literature: February 2019.

ESMO Open 2019 13;4(1):e000490. Epub 2019 Feb 13.

Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, CIBERONC, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435238PMC
February 2019

A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib.

Lung Cancer 2017 06 22;108:154-160. Epub 2017 Mar 22.

Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Badalona, Spain; Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain; Molecular Oncology Research Foundation (MORe), Barcelona, Spain; Universitat Autònoma de Barcelona (UAB) Campus Can Ruti, Carretera de Canyet s/n, 08916 Badalona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.009DOI Listing
June 2017

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

Clin Lung Cancer 2017 03 9;18(2):178-188.e4. Epub 2016 Nov 9.

Cancer Biology and Precision Medicine Program, Hospital Germans Trias i Pujol, Catalan Institute of Oncology, Badalona, Spain; Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain; Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.08.007DOI Listing
March 2017

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression.

Lung Cancer 2014 May 2;84(2):161-7. Epub 2014 Mar 2.

Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO, Badalona, Barcelona, Spain; Pangaea Biotech, Hospital Universitario Quirón, Dexeus, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.02.011DOI Listing
May 2014

Choroidal metastases from lung adenocarcinoma.

Clin Transl Oncol 2009 Oct;11(10):694-7

Department of Hematology and Medical Oncology, Hospital Clínico Universitario, Valencia, Spain.

View Article

Download full-text PDF

Source
October 2009

Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.

Melanoma Res 2009 Aug;19(4):211-4

Department of Dermatology, Instituto Valenciano de Oncologia, C/ Profesor Beltran Baguena, 8, Valencia 46009, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e3283281057DOI Listing
August 2009

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.

Breast Cancer Res Treat 2009 Apr 8;114(3):479-84. Epub 2008 May 8.

Medical Oncology Service, Hospital Clínico Universitario, Avda. Blasco Ibáñez, 17, 46011 Valencia, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-008-0018-1
Publisher Site
http://dx.doi.org/10.1007/s10549-008-0018-1DOI Listing
April 2009

[Neoadjuvant therapy for operable breast-cancer].

Med Clin (Barc) 2006 Mar;126(8):295-303

Servicio de Hematología y Oncología Médica, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13085484DOI Listing
March 2006

Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.

Melanoma Res 2005 Jun;15(3):169-77

Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.

View Article

Download full-text PDF

Source
June 2005